Chromosome aberration assays in genetic toxicology testing in vitro.
The chromosome aberration test using cultured mammalian cells is one of the sensitive methods to predict environmental mutagens and/or carcinogens, and is a complementary test to the Salmonella/microsome assay (Ames test). From our recent survey of 951 chemicals which have been tested for their clastogenicity in cultured mammalian cells such as Chinese hamster fibroblasts or human lymphocytes, it was noted that 47% of them are consistently positive either with or without metabolic activation. When the test was performed using the cell line CHL/IU, 39.2% (292/745) were found to be positive. However, 8% (36/447) of such clastogens were positive only at an extremely high concentration of more than 10 mM. About 11% (48/447) of clastogens such as diethylstilbestrol (DES) and methyl AalphaC (Glob-P-1) induced mainly polyploid cells. Most chemicals induced chromatid-type aberrations, some induce only break-type aberrations at relatively high dose levels, but others induce more exchange-type aberrations at relatively low dose levels. Clastogenic activities were compared among different clastogens, using the D20 value, which is the minimum dose (mg/ml) at which aberrations were found in 20% of metaphases. In addition, the translocation (TR) value was calculated from the incidence of cells with exchange-type aberrations. It was suggested that possible carcinogens are included in the group of compounds with relatively low D20 values, but with high TR values. Karyological analysis was performed, using a FISH painting probe prepared from No. 1 chromosome of CHO cells, on the clonal subline isolated after treatment with benzo(a)pyrene. However, no specific changes common to the agent were detected. Laser scanning cytometry (LSC) was also applied to screen for abnormal karyotypes. A translocation between particular chromosomes was reflected by the deletion of a DNA peak.
Ishidate
M
M
Chromosome Research Centre (CRC), Olympus Optical, 2-3 Kuboyama-cho, Hachioji, Tokyo 192-8512, Japan. m_ishidate@ot.olympus.co.jp
Miura
K F
KF
Sofuni
T
T
D001564:Benzo(a)pyrene / Q000633:toxicity; D002274:Carcinogens, Environmental / Q000032:analysis / Q000633:toxicity; D002478:Cells, Cultured; D002842:Chromatids / Q000378:metabolism; D002869:Chromosome Aberrations / Q000235:genetics*; D019457:Chromosome Breakage / Q000235:genetics; D002875:Chromosomes / Q000187:drug effects*; D002999:Clone Cells; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007564:Japan; D007621:Karyotyping / Q000379:methods; D007834:Lasers; D009152:Mutagenicity Tests / Q000379:methods; D009153:Mutagens / Q000633:toxicity*; D014178:Translocation, Genetic / Q000187:drug effects; D014481:United States
D002274:Carcinogens, Environmental; D009153:Mutagens; D001564:Benzo(a)pyrene